Kadimastem Kadimastem is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells (hESCs). | |||
Founding Date | Founding Date 1989 | Founding Date 2017 | Founding Date 2009 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Macierzysz, PL HQ | Locations Basel, CH HQ | Locations Ness Ziona, IL HQ |
Employees | Employees 361 | Employees 10 | Employees 11 |
Financial | |||
Revenue (est.) | Revenue (est.) zł282.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods zł157.1m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit zł128.4m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income zł3.4m (FY, 2025) | Net income N/A | Net income (₪26.6m) (FY, 2024) |
Kadimastem is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells (hESCs).
View company